Cite
APA Citation
Baraliakos, X., Schiff, M., Pavelka, K., Widmer, A., Porter, B., Gaillez, C., & , (n.d.). tHU0398 Secukinumab sustains individual clinical responses over time in patients with active ankylosing spondylitis: 2-year results from a phase 3 trial, measure 2. Annals of the rheumatic diseases, 76, 358. http://access.bl.uk/ark:/81055/vdc_100135155738.0x000058